Qiu XY - Search Results

1

The Prognostic and Therapeutic Value of PD-L1 in Glioma.

Chen RQ, Liu F, Qiu XY, Chen XQ. Chen RQ, et al. Among authors: qiu xy. Front Pharmacol. 2019 Jan 9;9:1503. doi: 10.3389/fphar.2018.01503. eCollection 2018. Front Pharmacol. 2019. PMID: 30687086 Free PMC article. Review.

2

The Binding of PD-L1 and Akt Facilitates Glioma Cell Invasion Upon Starvation via Akt/Autophagy/F-Actin Signaling.

Chen RQ, Xu XH, Liu F, Li CY, Li YJ, Li XR, Jiang GY, Hu F, Liu D, Pan F, Qiu XY, Chen XQ. Chen RQ, et al. Among authors: qiu xy. Front Oncol. 2019 Dec 3;9:1347. doi: 10.3389/fonc.2019.01347. eCollection 2019. Front Oncol. 2019. PMID: 31850228 Free PMC article.

3

Advances in Hypoxia-Mediated Mechanisms in Hepatocellular Carcinoma.

Xiong XX, Qiu XY, Hu DX, Chen XQ. Xiong XX, et al. Among authors: qiu xy. Mol Pharmacol. 2017 Sep;92(3):246-255. doi: 10.1124/mol.116.107706. Epub 2017 Feb 27. Mol Pharmacol. 2017. PMID: 28242743 Review.

4

Neuroglobin boosts axon regeneration during ischemic reperfusion via p38 binding and activation depending on oxygen signal.

Xiong XX, Pan F, Chen RQ, Hu DX, Qiu XY, Li CY, Xie XQ, Tian B, Chen XQ. Xiong XX, et al. Among authors: qiu xy. Cell Death Dis. 2018 Feb 7;9(2):163. doi: 10.1038/s41419-017-0260-8. Cell Death Dis. 2018. PMID: 29416029 Free PMC article.

5

PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation.

Qiu XY, Hu DX, Chen WQ, Chen RQ, Qian SR, Li CY, Li YJ, Xiong XX, Liu D, Pan F, Yu SB, Chen XQ. Qiu XY, et al. Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1754-1769. doi: 10.1016/j.bbadis.2018.03.002. Epub 2018 Mar 3. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29510196 Free article.

6

Piperlongumine inhibits migration of glioblastoma cells via activation of ROS-dependent p38 and JNK signaling pathways.

Liu QR, Liu JM, Chen Y, Xie XQ, Xiong XX, Qiu XY, Pan F, Liu D, Yu SB, Chen XQ. Liu QR, et al. Among authors: qiu xy. Oxid Med Cell Longev. 2014;2014:653732. doi: 10.1155/2014/653732. Epub 2014 May 22. Oxid Med Cell Longev. 2014. PMID: 24967005 Free PMC article.

7

Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization.

Liu D, Qiu XY, Wu X, Hu DX, Li CY, Yu SB, Pan F, Chen XQ. Liu D, et al. Among authors: qiu xy. Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):165-172. doi: 10.1016/j.bbrc.2017.10.061. Epub 2017 Oct 14. Biochem Biophys Res Commun. 2017. PMID: 29037814

8

Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP.

Chen Y, Liu JM, Xiong XX, Qiu XY, Pan F, Liu D, Lan SJ, Jin S, Yu SB, Chen XQ. Chen Y, et al. Among authors: qiu xy. Oncotarget. 2015 Mar 20;6(8):6406-21. doi: 10.18632/oncotarget.3444. Oncotarget. 2015. PMID: 25788268 Free PMC article.

9

Neuroglobin - recent developments.

Qiu XY, Chen XQ. Qiu XY, et al. Biomol Concepts. 2014 Jun;5(3):195-208. doi: 10.1515/bmc-2014-0011. Biomol Concepts. 2014. PMID: 25372753 Free article. Review.

10

Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways.

Xiong XX, Liu JM, Qiu XY, Pan F, Yu SB, Chen XQ. Xiong XX, et al. Among authors: qiu xy. Acta Pharmacol Sin. 2015 Mar;36(3):362-74. doi: 10.1038/aps.2014.141. Epub 2015 Jan 26. Acta Pharmacol Sin. 2015. PMID: 25619389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page